Trials / Unknown
UnknownNCT02961478
Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University Hospital, Angers · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
IOXSOR study's purpose to determine the frequency of non resolutive renal failure (estimated by the clearance of iohexol) at end of stay in ICU patients who have had acute renal failure episode.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IOHEXOL | Estimate iohexol clearance at the end of stay in intensive care for patients who had an episode of acute renal failure. |
Timeline
- Start date
- 2017-02-10
- Primary completion
- 2020-06-01
- Completion
- 2020-12-01
- First posted
- 2016-11-11
- Last updated
- 2019-03-19
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02961478. Inclusion in this directory is not an endorsement.